HPC Longevity Intelligence
Monthly briefing · St. Gallen
Science · Industry · Capital

See the next era of health before it becomes consensus.

A concise intelligence briefing on frontier science, health innovation and the market forces reshaping longevity.

Built through the Human Performance Club ecosystem. Originated at the University of St. Gallen and informed by a growing network across Switzerland’s scientific, clinical and entrepreneurial landscape, including the ETH Zurich innovation ecosystem.
Snow-covered Alpine range in Switzerland
Switzerland Research · Capital · Implementation
The strategic context

Health is entering a period of structural change.

Advances in biomarkers, diagnostics, artificial intelligence, therapeutics and preventive care are changing when disease can be detected and how health can be protected. The consequences extend across insurance, pharmaceuticals, technology, employment and capital allocation. Decision makers need a disciplined view of the evidence, the market and the institutions moving first.

01 Biomarkers and early detection
02 AI-enabled discovery and care
03 Prevention economics and delivery
04 Longevity capital and regulation
Editorial scope

The developments that will define the longevity economy.

Each edition identifies the scientific advances, commercial signals and institutional decisions with the greatest potential to change health outcomes and the allocation of capital.

01 · SCIENCE

Frontier research

Selected findings from ageing biology, preventive medicine, neuroscience, nutrition and performance science, assessed for evidence quality and real-world significance.

02 · TECHNOLOGY

Health innovation

Diagnostics, artificial intelligence, omics, digital health and new models of care moving from research into clinical and commercial application.

03 · MARKETS

Industry and capital

Market formation, capital flows, business models, regulation and reimbursement shaping where durable value can emerge across the longevity sector.

04 · DECISIONS

Strategic implications

Clear consequences for corporate leaders, investors, founders and the next generation entering a field that is becoming central to economic and social resilience.

Blue glacial ice formations under an open sky
The intelligence network

Research gains value when it reaches the decisions that determine adoption.

HPC brings scientific, clinical, entrepreneurial and financial perspectives into one platform. Our forums, expert sessions and working relationships connect developments that are usually assessed in isolation: new evidence, founder activity, institutional priorities and the capital behind translation.

Rooted at HSG. Connected across Switzerland’s health, technology and investment ecosystem. Informed by the people building, testing and financing the next generation of health solutions.
Editorial discipline
  • Primary literature and direct institutional sources
  • Evidence quality separated clearly from early signals
  • Commercial relevance assessed without promotional language
  • Implications stated for strategy, implementation and capital
Built for consequential decisions

For the people allocating capital, building companies, setting strategy and entering the field.

Corporate decision makers
Investors and allocators
Founders and operators
Students and researchers
HPC Longevity Intelligence

The field is moving faster than most organizations can interpret it.

Receive the developments that matter, with the evidence and market context required to act intelligently.

By subscribing, you consent to receive HPC Intelligence emails. Unsubscribe at any time. Data protection .

Human Performance Club · University of St. Gallen Evidence · Innovation · Longevity economy
Scroll to Top